ES8203963A1 - Un procedimiento para la preparacion de una macrolida - Google Patents

Un procedimiento para la preparacion de una macrolida

Info

Publication number
ES8203963A1
ES8203963A1 ES502981A ES502981A ES8203963A1 ES 8203963 A1 ES8203963 A1 ES 8203963A1 ES 502981 A ES502981 A ES 502981A ES 502981 A ES502981 A ES 502981A ES 8203963 A1 ES8203963 A1 ES 8203963A1
Authority
ES
Spain
Prior art keywords
macrolide
ch2oh
formula
macrolide antibiotics
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502981A
Other languages
English (en)
Other versions
ES502981A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/156,855 external-priority patent/US4321362A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8203963A1 publication Critical patent/ES8203963A1/es
Publication of ES502981A0 publication Critical patent/ES502981A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/54—Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Processing Of Solid Wastes (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UNA MACROLIDA, ASI COMO DE SUS ESTERES Y SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA Q ES CH2OH O CHO. CONSISTE EN EL CULTIVO DE STREPTOMYCES FRADIAE NRRL 12171 EN CONDICIONES AEROBIAS SUMERGIDAS HASTA OBTENER UNA CANTIDAD SUSTANCIAL DE ACTIVIDAD ANTIBIOTICA PARA QUE SE PRODUZCA LA MACROLIDA. TAMBIEN SE PUEDE REDUCIR QUIMICAMENTE LA 23-DESMICINOSILTILOSINA PARA OBTENER LA MACROLIDA DE FORMULA (I), EN LA QUE Q ES CH2OH. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIBIOTICOS.
ES502981A 1980-06-12 1981-06-11 Un procedimiento para la preparacion de una macrolida Granted ES502981A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/156,855 US4321362A (en) 1980-06-12 1980-06-12 De(mycinosyloxy)tylosin and process for its production

Publications (2)

Publication Number Publication Date
ES8203963A1 true ES8203963A1 (es) 1982-04-16
ES502981A0 ES502981A0 (es) 1982-04-16

Family

ID=22561375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502981A Granted ES502981A0 (es) 1980-06-12 1981-06-11 Un procedimiento para la preparacion de una macrolida

Country Status (24)

Country Link
EP (1) EP0042694B1 (es)
JP (1) JPS5731698A (es)
KR (1) KR840001957B1 (es)
AT (1) ATE6468T1 (es)
AU (1) AU544358B2 (es)
CA (1) CA1172190A (es)
CS (1) CS225842B2 (es)
DD (1) DD159645A5 (es)
DE (1) DE3162501D1 (es)
DK (1) DK255581A (es)
ES (1) ES502981A0 (es)
FI (1) FI811827L (es)
GB (1) GB2077730B (es)
GR (1) GR75276B (es)
HU (1) HU189979B (es)
IE (1) IE51613B1 (es)
IL (1) IL63076A (es)
NZ (1) NZ197360A (es)
PH (1) PH15924A (es)
PT (1) PT73164B (es)
RO (1) RO81017A (es)
SU (1) SU1134120A3 (es)
YU (1) YU144281A (es)
ZA (1) ZA813578B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4435388A (en) 1982-06-10 1984-03-06 Schering Corporation Tylosin 20-imino-20-deoxo-4"-acyl derivatives, pharmaceutical compositions and method of use
JPS58219197A (ja) * 1982-06-15 1983-12-20 Sanraku Inc マクロライド系抗生物質の誘導体
US4436729A (en) * 1982-06-30 1984-03-13 Schering Corporation 23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1428452A (fr) * 1958-10-29 1966-02-18 Lilly Co Eli Méthodes de production de nouveaux composés organiques azotés, tels que la tylosine et la desmycosine
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof

Also Published As

Publication number Publication date
DE3162501D1 (en) 1984-04-12
DK255581A (da) 1981-12-13
AU544358B2 (en) 1985-05-23
PT73164B (en) 1982-07-16
CA1172190A (en) 1984-08-07
IL63076A0 (en) 1981-09-13
PH15924A (en) 1983-04-26
GR75276B (es) 1984-07-13
SU1134120A3 (ru) 1985-01-07
DD159645A5 (de) 1983-03-23
PT73164A (en) 1981-07-01
ZA813578B (en) 1983-01-26
GB2077730B (en) 1984-06-20
JPS5731698A (en) 1982-02-20
AU7144781A (en) 1981-12-17
CS225842B2 (en) 1984-02-13
ATE6468T1 (de) 1984-03-15
NZ197360A (en) 1984-03-30
KR840001957B1 (ko) 1984-10-26
FI811827L (fi) 1981-12-13
EP0042694B1 (en) 1984-03-07
IL63076A (en) 1984-07-31
GB2077730A (en) 1981-12-23
IE811296L (en) 1981-12-12
YU144281A (en) 1983-09-30
EP0042694A1 (en) 1981-12-30
ES502981A0 (es) 1982-04-16
RO81017A (ro) 1983-02-01
KR830006430A (ko) 1983-09-24
HU189979B (en) 1986-08-28
IE51613B1 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
NO900807D0 (no) Nye organiske forbindelser og fremgangsmaate for fremstilling derav.
ES8304117A1 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
GEP19960475B (en) Method of preparing hydrated crystalline form of sodium salt of 3-acetoxymethyl-7-/2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido/-ceph-3-em-4-carboxilic acid, sin-isomer
ES8203963A1 (es) Un procedimiento para la preparacion de una macrolida
ES8505207A1 (es) Un procedimiento para la preparacion de una macrolida
ES446459A1 (es) Procedimiento para preparar el antibiotico nikkomicina.
GB1235599A (en) Lincomycin phosphate derivatives and pharmaceutical compositions containing them
ES422433A1 (es) Un procedimiento para la produccion del antibiotico a-287.
GB1433417A (en) Antibiotic a-2315 and process for preparation thereof
ES8206622A1 (es) Un procedimiento para la preparacion de una nueva macrolida
JPS57170189A (en) Dc-52 and its preparation
ES436218A1 (es) Procedimiento para la obtencion de derivados de fenoxialca- nol.
EG16889A (en) Improvements in or relating to macrolide antibiotics
NO164422C (no) Fremgangsmaate for fremstilling av en sur polycyklisk etermed antibiotisk virkning.
JPS52108092A (en) Preparation of bicyclomycin
ES455805A1 (es) Un procedimiento para preparar derivados de olecendomina.
ES439841A1 (es) Un procedimiento para producir el compuesto 38.295 antibio- tico.
ES485529A1 (es) Un procedimiento para la produccion de ravidomicina
ES313098A1 (es) Procedimiento para la preparacion de lincomicina d.
ES379758A1 (es) Procedimiento para producir un antibiotico de macrolida.
GB2015526A (en) Naphthopyrans
ES479060A1 (es) Procedimiento para preparar derivados del naftaleno.
ATE137502T1 (de) Saures polycyclisches etherantibiotikum
IE790991L (en) Antibiotic produced by cultivating streptomyces species¹nrrl 11298
ES464004A1 (es) Un metodo para la purificacion de 4-metil-2,6-di-terbutilfe-nol.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401